ロード中...
A43 LONG-TERM EFFICACY AND SAFETY OF OBETICHOCLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL
BACKGROUND: Obeticholic acid (OCA), a potent farnesoid X receptor agonist, is approved as second-line treatment for primary biliary cholangitis (PBC) in patients with an incomplete response or intolerance to ursodeoxycholic acid. AIMS: We evaluated the effect of OCA in PBC patients enrolled in the P...
保存先:
| 出版年: | J Can Assoc Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958753/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwab002.041 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|